WASHINGTON—The Food and Drug Administration Wednesday gave marketing clearance for a device that can potentially revamp stroke care by allowing paramedics in the field to diagnose severe strokes requiring specialized treatment.
The Lucid Robotic System is aimed at one of the central dilemmas of modern neurology: How to quickly identify patients with the most severe strokes who could benefit from being taken immediately to hospitals that can perform a complex clot-removal procedure, potentially helping to avoid major disability.
...